[Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].
D000284:Administration, Oral; D000818:Animals; D001932:Brain Neoplasms / Q000139:chemically induced; D002273:Carcinogens; D055598:Chemical Phenomena; D002621:Chemistry; D004789:Enzyme Activation; D005260:Female; D007279:Injections, Subcutaneous; D007680:Kidney Neoplasms / Q000139:chemically induced; D007928:Lethal Dose 50; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D051381:Rats; D011919:Rats, Inbred Strains; D012878:Skin Neoplasms / Q000139:chemically induced; D013329:Structure-Activity Relationship; D014226:Triazenes / Q000378:metabolism / Q000633:toxicity
D002273:Carcinogens; D014226:Triazenes
Carcinogene Wirkung von 13 Aryldialkyltriazenen an BD-Ratten